...
首页> 外文期刊>Iranian Journal of Medical Sciences >Comparison between Topical and Oral Tranexamic Acid in Management of Traumatic Hyphema
【24h】

Comparison between Topical and Oral Tranexamic Acid in Management of Traumatic Hyphema

机译:外用和口服氨甲环酸治疗创伤性先兆的比较

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: We sought to determine the efficacy of topical tranexamic acid (5%) in the management of traumatic hyphema. Methods: Thirty eyes with gross traumatic hyphema were enrolled in this study. The patients were treated with tranexamic acid (5%) eye drop every 6 hours for 5 days. The main outcome measures were best corrected visual acuity (BCVA), Intra-ocular pressure (IOP), day of clot absorption, and rate of rebleeding. These parameters were evaluated daily for 4 days and thereafter at the 8th and 14th days after treatment. The patients were also compared with two historical control groups of patients (80 eyes) with traumatic hyphema; the first control group was treated with oral placebo and the other group was treated with oral tranexamic acid at our department. Result: Prior to treatment, the mean logarithm of the minimum angle of resolution (logMAR) BCVA was 0.59±0.62. BCVA was increased to 0.08±0.14 at day 14 (P&0.001) and the mean IOP before treatment was 13.7±3.9 mm Hg, which was reduced to 11.4±1.8 mm Hg at day 14 (P=0.004). Rebleeding occurred in one (3.3%) patient on the 4th day post treatment. Comparison between the case group and the other two historical control groups with respect to the rebleeding rate demonstrated statistically significant differences between the case group and the first control group (P=0.008) but no statistically significant differences between the case group and the second control group (P=0.25). Conclusion: Topical tranexamic acid seems promising in the management of traumatic hyphema. However, the small sample size of the present study precludes the conclusion that topical tranexamic acid can replace the oral tranexamic acid.
机译:背景:我们试图确定局部氨甲环酸(5%)在创伤性前房积血的治疗中的功效。方法:本研究招募了30只患有严重外伤性前房积血的眼睛。每6小时用氨甲环酸(5%)滴眼液治疗患者5天。主要结局指标为最佳矫正视力(BCVA),眼内压(IOP),血块吸收天数和再出血率。每天评估这些参数,持续4天,然后在治疗后的第8和14天进行评估。还将患者与两个历史性对照组(80眼)有外伤性前房积血的患者进行了比较。第一个对照组接受口服安慰剂治疗,另一组接受口服氨甲环酸治疗。结果:治疗前,最小分辨角(logMAR)BCVA的平均对数为0.59±0.62。 BCVA在第14天增加至0.08±0.14(P <0.001),并且治疗前的平均IOP为13.7±3.9mm Hg,在第14天降低至11.4±1.8mm Hg(P = 0.004)。治疗后第4天,一名(3.3%)患者出现再出血。病例组与其他两个历史对照组之间的再出血率比较表明,病例组与第一个对照组之间存在统计学上的显着差异(P = 0.008),但病例组与第二个对照组之间没有统计学上的显着差异(P = 0.25)。结论:外用氨甲环酸在创伤性前房积血的治疗中似乎很有希望。然而,本研究的小样本量排除了局部用氨甲环酸可以代替口服氨甲环酸的结论。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号